Biophysical Characterisation of Calumenin as a Charged F508del-CFTR Folding Modulator

PLoS ONE - United States
doi 10.1371/journal.pone.0104970
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Most F508del-CFTR Is Targeted to Degradation at an Early Folding Checkpoint and Independently of Calnexin

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2005English

A Kinase-Directed Approach to Rescue Functionality of F508del CFTR

Postdoc Journal
2016English

Functional Rescue of F508del-CFTR Using Small Molecule Correctors

Frontiers in Pharmacology
Pharmacology
2012English

An Unexpected Effect of TNF-α on F508del-CFTR Maturation and Function

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2015English

Identification of a Novel Water-Soluble Activator of Wild-Type and F508del CFTR: GPact-11a

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Prs16 - Modeled Survival Gains of Patients With Cystic Fibrosis (Cf) Aged ≥12 Years Heterozygous for F508del-CFTR and a Residual Function Mutation (F508del/Rf) Treated With the Cf Transmembrane Conductance Regulator Modulator (Cftrm) Tezacaftor/Ivacaftor (Tez/Iva)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Bioactive Thymosin Alpha-1 Does Not Influence F508del-CFTR Maturation and Activity

Scientific Reports
Multidisciplinary
2019English

Thymosin Α-1 Does Not Correct F508del-CFTR in Cystic Fibrosis Airway Epithelia

JCI insight
Medicine
2018English

Thymosin Α-1 Does Not Correct F508del-CFTR in Cystic Fibrosis Airway Epithelia

JCI insight
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy